癌症治疗的胃肠道副作用。
Gastrointestinal side effects of cancer treatments.
作者信息
O'Reilly Mary, Mellotte Gregory, Ryan Barbara, O'Connor Anthony
机构信息
Department of Gastroenterology, Tallaght University Hospital/Trinity College Dublin, Ireland.
Department of Gastroenterology, Tallaght University Hospital/Trinity College Dublin, Belgard Road, Tallaght, Dublin, D24NR0A, Ireland.
出版信息
Ther Adv Chronic Dis. 2020 Nov 27;11:2040622320970354. doi: 10.1177/2040622320970354. eCollection 2020.
Abstract
Cancer survival rates have significantly improved over the last number of years due to advancements in cancer therapies. Unfortunately this has come at a cost. Therapeutic side effects are feared complications of therapy that may result in decreased quality of life and early cessation of the therapy, which can have knock-on effects on outcomes. This article outlines the main gastrointestinal side effects seen with radiation therapy, chemotherapy and immunotherapy, and discusses appropriate investigation and management.
摘要
在过去数年中，由于癌症治疗技术的进步，癌症生存率有了显著提高。不幸的是，这是有代价的。治疗副作用是令人担忧的治疗并发症，可能导致生活质量下降和治疗提前终止，进而对治疗结果产生连锁反应。本文概述了放射治疗、化疗和免疫治疗中常见的主要胃肠道副作用，并讨论了适当的检查和处理方法。
相似文献
1
Gastrointestinal side effects of cancer treatments.癌症治疗的胃肠道副作用。
Ther Adv Chronic Dis. 2020 Nov 27;11:2040622320970354. doi: 10.1177/2040622320970354. eCollection 2020.
2
Nonendoscopic therapies for the management of radiation-induced rectal bleeding.非内镜治疗在放射性直肠出血中的应用。
Curr Opin Support Palliat Care. 2013 Jun;7(2):175-82. doi: 10.1097/SPC.0b013e32835f3e00.
3
[Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment?].[放疗的急性胃肠道副作用。治疗中确定的是什么？]
Strahlenther Onkol. 1996 Feb;172(2):53-63.
4
Management of radiation proctitis.放射性直肠炎的处理。
Gastroenterol Clin North Am. 2013 Dec;42(4):913-25. doi: 10.1016/j.gtc.2013.08.004.
5
The gastrointestinal complications of oncologic therapy.肿瘤治疗的胃肠道并发症。
Gastroenterol Clin North Am. 2010 Sep;39(3):629-47. doi: 10.1016/j.gtc.2010.08.004.
7
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?放疗与免疫治疗联合治疗肺癌：正常组织毒性改变是否会带来限制？
Int J Mol Sci. 2018 Dec 21;20(1):24. doi: 10.3390/ijms20010024.
8
Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum.胃肠道黏膜炎：聚焦于化疗和放疗对直肠影响的治疗
Int J Pharm Compd. 2012 Mar-Apr;16(2):117-24.
9
Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis.氩等离子体凝固术是治疗难治性出血性放射性直肠炎的一种有效方法。
Dis Colon Rectum. 2001 Dec;44(12):1759-65; discussion 1771. doi: 10.1007/BF02234451.
10
Chronic radiation enteritis.慢性放射性肠炎。
Clin Oncol (R Coll Radiol). 2010 Feb;22(1):70-83. doi: 10.1016/j.clon.2009.10.003. Epub 2009 Nov 7.
引用本文的文献
1
Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.植物化学物质作为女性癌症替代治疗策略的作用机制及益处
Chin Herb Med. 2025 Apr 11;17(3):448-463. doi: 10.1016/j.chmed.2025.04.002. eCollection 2025 Jul.
2
Understanding the Diverse Experiences of Those Living with and Beyond Cancer: Implications for Personalised Care from a Latent Profile Analysis of HRQoL.了解癌症患者及康复者的多样经历：基于健康相关生活质量潜在类别分析对个性化护理的启示
Cancers (Basel). 2025 May 19;17(10):1698. doi: 10.3390/cancers17101698.
3
Chinese clinical practice guidelines for the prevention and treatment of radiation-induced rectal injury.放射性直肠损伤防治中国临床实践指南
Precis Radiat Oncol. 2023 Dec 25;7(4):237-255. doi: 10.1002/pro6.1217. eCollection 2023 Dec.
4
The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.PRMT5的表达与结肠癌术后化疗结果相关。
BMC Cancer. 2025 Apr 23;25(1):760. doi: 10.1186/s12885-025-14161-5.
5
Association of GI symptoms with health-related quality of life in cancer patients undergoing chemotherapy: a prospective study.化疗癌症患者胃肠道症状与健康相关生活质量的关联：一项前瞻性研究。
Support Care Cancer. 2025 Apr 1;33(4):336. doi: 10.1007/s00520-025-09400-1.
6
Drug prescription for the management of gastrointestinal and skin symptoms in cancer patients by advanced practice nurses in China: a Delphi method.中国高级实践护士对癌症患者胃肠道和皮肤症状管理的药物处方：德尔菲法
BMJ Open. 2025 Mar 31;15(3):e089803. doi: 10.1136/bmjopen-2024-089803.
7
Anticancer Activity of Ether Derivatives of Chrysin.白杨素醚衍生物的抗癌活性
Molecules. 2025 Feb 19;30(4):960. doi: 10.3390/molecules30040960.
8
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.微生物群完整性增强抗癌药物的疗效和安全性。
Biomedicines. 2025 Feb 10;13(2):422. doi: 10.3390/biomedicines13020422.
9
Mitigating digestive complications and neutropenia in pediatric leukemia through a Persian medicine product of whole wheat-based dietary intervention: a randomized triple-blind placebo-controlled trial.通过基于全麦饮食干预的波斯医药产品减轻小儿白血病患者的消化并发症和中性粒细胞减少症：一项随机三盲安慰剂对照试验
Support Care Cancer. 2025 Jan 23;33(2):117. doi: 10.1007/s00520-025-09177-3.
10
Advancements and Challenges in the Image-Based Diagnosis of Lung and Colon Cancer: A Comprehensive Review.肺癌和结肠癌基于图像诊断的进展与挑战：综述
Cancer Inform. 2024 Oct 16;23:11769351241290608. doi: 10.1177/11769351241290608. eCollection 2024.
本文引用的文献
1
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.奥氮平 5 毫克联合标准止吐疗法预防化疗引起的恶心和呕吐（J-FORCE）：一项多中心、随机、双盲、安慰剂对照、3 期临床试验。
Lancet Oncol. 2020 Feb;21(2):242-249. doi: 10.1016/S1470-2045(19)30678-3. Epub 2019 Dec 11.
2
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management.免疫检查点抑制剂相关的胃肠道和肝脏不良事件及其管理。
Therap Adv Gastroenterol. 2019 Nov 5;12:1756284819884196. doi: 10.1177/1756284819884196. eCollection 2019.
3
Immune checkpoint inhibitor-induced colitis: A comprehensive review.免疫检查点抑制剂诱导的结肠炎：综述
World J Clin Cases. 2019 Feb 26;7(4):405-418. doi: 10.12998/wjcc.v7.i4.405.
4
Overview of the prevention and management of CINV.CINV 的预防和管理概述。
Am J Manag Care. 2018 Oct;24(18 Suppl):S391-S397.
5
Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer.益生菌用于预防或治疗癌症患者化疗或放疗相关腹泻。
Cochrane Database Syst Rev. 2018 Aug 31;8(8):CD008831. doi: 10.1002/14651858.CD008831.pub3.
6
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.免疫疗法毒性管理：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225.
7
Antioxidant Supplementation: A Linchpin in Radiation-Induced Enteritis.抗氧化剂补充：放射性肠炎的关键因素
Technol Cancer Res Treat. 2017 Dec;16(6):676-691. doi: 10.1177/1533034617707598. Epub 2017 May 22.
8
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.癌症患者 CTLA-4 和 PD-1/PD-L1 抑制剂关键免疫相关不良事件的综合荟萃分析。
Cancer Immunol Res. 2017 Apr;5(4):312-318. doi: 10.1158/2326-6066.CIR-16-0237. Epub 2017 Feb 28.
9
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.维多珠单抗治疗免疫检查点抑制剂诱导的小肠结肠炎。
Cancer Immunol Immunother. 2017 May;66(5):581-592. doi: 10.1007/s00262-017-1962-6. Epub 2017 Feb 15.
10
A review of serious adverse effects under treatment with checkpoint inhibitors.检查点抑制剂治疗相关严重不良反应综述。
Curr Opin Oncol. 2017 Mar;29(2):136-144. doi: 10.1097/CCO.0000000000000358.
Zotero 插件